ADAM9, a metalloprotease, cleaves and re…

The University of Nebraska Medical Center (UNMC), a state institution under the Board of Regents of the University of Nebraska, awarded a Purchase Order (PO #4800184475) to MedChemExpress LLC on March 5, 2026, for the procurement of ADAM9, a metalloprotease chemical compound (material number HY-P77867). The contract value is $185.00 for one unit. The period of performance extends from the award date of March 5, 2026, through the scheduled delivery date of March 19, 2026. MedChemExpress LLC is based in Monmouth Junction, New Jersey, and the place of performance is the UNMC facility located at 601 Saddle Creek Road, Omaha, Nebraska.

The purchase order specifies Net 30 payment terms with Free on Board (F.O.B.) Destination shipping, with freight costs to be prepaid by the vendor. Payment will be made through Nebraska State Treasury warrants. The vendor is required to acknowledge acceptance within 10 days of the order date and must include the purchase order number on all packages, invoices, and related documentation. The order reflects UNMC's tax-exempt status and is processed through the ARIBA procurement system, with delivery directed to Erin McIntyre, LTC 11727, at the specified Omaha facility.